Richard Haynes

Has grant

Charles Sturt University

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Drug Delivery Drug Delivery professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Rational Development of Combinations of Known and Novel Drugs for Chemotherapy of Cancer

Open Date: 2016-01-01

Close Date: 2018-12-01

Grant: Close

MAL-TB REDOX - Development to the Clinical Phase of Oxidant and Redox Drug Combinations for Treatment of Malaria, TB and Related Diseases

Open Date: 2014-01-01

Close Date: 2018-06-01

Grant: Close

Development of drug combinations linked by treatment modalities

Open Date: 2014-01-01

Close Date: 2019-12-01

Articles (14)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Andrew Hemphill

University of Bern

SWITZERLAND

View details

Christopher Parkinson

Charles Sturt University

AUSTRALIA

View details

Luis Miguel Ortega-Mora

Universidad Complutense de Madrid

SPAIN

View details

Ho Ning Wong

Charles Sturt University

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Richard Haynes

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (14)

Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins

Artemisia Species and Their Active Constituents for Treating Schistosomiasis

The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems

Combining computational and experimental evidence on the activity of antimalarial drugs on papain-like protease of SARS-CoV-2

Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation

In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline-O-Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites

Discovery of artemisinin in Artemisia annua, its current production, and relevance to sub-Saharan Africa

Assessment of Thermal and Hydrolytic Stabilities and Aqueous Solubility of Artesunate for Formulation Studies

Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice

Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System

The Development of Dermal Self-Double-Emulsifying Drug Delivery Systems: Preformulation Studies as the Keys to Success

Dual production of solar energy and important plant-derived active pharmaceutical ingredients: Artemisinin, a pilot study

Control of 11-Aza:4-X-SalA Cocrystal Polymorphs Using Heteroseeds That Switch On/Off Halogen Bonding

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue

Collaborators (4)

Andrew Hemphill

Christopher Parkinson

Luis Miguel Ortega-Mora

Ho Ning Wong

Make your next move.